HONG KONG – Opening the door wide to a broad range of investments, a European biotech investment firm is working with a diversified Chinese biotech company to invest in and introduce mature and innovative technologies to Greater China. Read More
Dr. Reddy's Laboratories Ltd., of Hyderabad, India, said it filed three 505(b)(2) new drug applications to the FDA, seeking approval of DFD-01, a corticosteroid delivered in a non-irritating spray platform, intended for the treatment of patients suffering from psoriasis; DFD-09, a modified-release oral tetracycline intended for the treatment of rosacea; and DFN-11, a drug-device combination product intended to treat acute migraine. Read More
SHANGHAI – Shanghai-based Ark Biosciences Inc. has received financial backing, the amount undisclosed, to usher its lead candidate through phase II trials in Australia and possibly other sites. Ark is developing AK0529, an asset licensed from Roche AG to treat respiratory syncytial virus (RSV), a significant cause of death for children younger than 5 and the elderly. Read More
HONG KONG – Japanese scientists have used an advanced high-energy radiation particle accelerator to elucidate the structure of two receptors of the adipocyte-derived hormone, adiponectin, which could lead to the development of new treatments for obesity-related diseases, in particular type 2 diabetes. Read More
Taxus Cardium Pharmaceuticals Group Inc. inked a new deal with its Chinese investor to help fund a recently launched subsidiary aimed at advancing Generx (alferminogene tadenovec [Ad5FGF-4]), an angiogenic gene therapy candidate that has been in development for nearly 20 years, but may be finally reaching the finish line just as interest is reigniting the overall space. Read More
As health care across the globe shifts to a more patient-focused model, one of the challenges is getting patients to be more accountable for their own health. Read More
TOKYO – Japan is taking further steps to speed up reviews of innovative new drug and medical device applications through a new Sakigake designation. Sakigake roughly translates into "leading the way." Read More
